how to take retatrutide The Dosage Chart retatrutide dose Anyone else taking
Description
A total of 3050% of patients taking this class of drug at clinically licensed doses experience nausea 15
doi: 10.1056/NEJMcibr2409089
Another study published by Diabetes, Obesity & Metabolism in June 2025 further supported this link, concluding that the five-year risk of developing NAION doubled in patients using GLP-1 drugs compared to non-users
doi: 10.1097/MLR.0000000000000565 [DOI] [PMC free article] [PubMed] [Google Scholar] 23.Luo J, Feldman R, Callaway Kim K, et al
Long-acting injectables may become initial treatments, followed by oral maintenance therapies
Promote balanced blood sugar for steadier energy and better appetite control, helping you stick to your plan and see results
